文献速递瓣膜病与结构性心脏病

经导管主动脉瓣置换术的操作经验与结局关系:STS/ACC TVT注册研究

Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

该研究基于2011至2015年395家医院提交至TVT注册的42,988例商业TAVR手术,评估医院手术量与患者结局的关系。结果显示手术量增加与住院风险调整后死亡率、血管并发症和出血减少相关,但与卒中无关;从第1例至第400例,风险调整后不良结局下降。

要点

  • 医院TAVR手术量增加与住院风险调整后死亡率、血管并发症和出血减少相关。
  • 手术量与卒中无显著关联(p=0.14)。
  • 前100例血管和出血并发症风险较高,提示学习曲线效应。

核心结论

  • 美国TAVR初始开展阶段,经验增加与更好的结局相关。
  • 该关联提示将经验集中于高容量心脏瓣膜中心可能改善结局。

研究设计与样本

  • 基于STS/ACC TVT注册的回顾性队列研究。
  • 纳入2011至2015年395家医院提交的42,988例商业TAVR手术。

主要发现

  • 手术量增加与住院风险调整后死亡率(p<0.02)、血管并发症(p<0.003)和出血(p<0.001)降低相关。
  • 手术量与卒中无显著关联(p=0.14)。
  • 从第1例至第400例,风险调整后死亡率从3.57%降至2.15%。
  • 从第1例至第400例,风险调整后出血从9.56%降至5.08%。
  • 从第1例至第400例,风险调整后血管并发症从6.11%降至4.20%,卒中从2.03%降至1.66%。

临床怎么用

  • 考虑将TAVR经验集中于高容量心脏瓣膜中心以改善结局。
  • 关注前100例的血管和出血并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcatheter aortic valve replacement (TAVR) has been introduced into U.S. clinical practice with efforts to optimize outcomes and minimize the learning curve. OBJECTIVES: The goal of this study was to assess the degree to which increasing experience during the introduction of this procedure, separated from other outcome determinants including patient and procedural characteristics, is associated with outcomes. METHODS: The authors evaluated the association of hospital TAVR volume and patient outcomes for TAVR by using data from 42,988 commercial procedures conducted at 395 hospitals submitting to the Transcatheter Valve Therapy Registry from 2011 through 2015. Outcomes assessed included adjusted and unadjusted in-hospital major adverse events. RESULTS: Increasing site volume was associated with lower in-hospital risk-adjusted outcomes, including mortality (p < 0.02), vascular complications (p < 0.003), and bleeding (p < 0.001) but was not associated with stroke (p = 0.14). From the first case to the 400th case in the volume-outcome model, risk-adjusted adverse outcomes declined, including mortality (3.57% to 2.15%), bleeding (9.56% to 5.08%), vascular complications (6.11% to 4.20%), and stroke (2.03% to 1.66%). Vascular and bleeding volume-outcome associations were nonlinear with a higher risk of adverse outcomes in the first 100 cases. An association of procedure volume with risk-adjusted outcomes was also seen in the subgroup having transfemoral access. CONCLUSIONS: The initial adoption of TAVR into practice in the United States showed that increasing experience was associated with better outcomes. This association, whether deemed a prolonged learning curve or a manifestation of a volume-outcome relationship, suggested that concentrating experience in higher volume heart valve centers might be a means of improving outcomes. (STS/ACC Transcatheter Valve Therapy Registry [TVT Registry]; NCT01737528).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Carroll JD, Vemulapalli S, Dai D, et al. Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry. J Am Coll Cardiol. 2017. PMID: 28662805. doi:10.1016/j.jacc.2017.04.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。